As expected, each independent condition, HDAC6KD, and anti-PD-1 antibody were able to reduce tumor growth (Fig. 4E and Suppl. 5A) and improve survival (Fig. 4F) when compared to the non-treated group. This evidence concerns the gene PDCD1 and neoplasm.